Gujarat Themis Biosyn Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 17.4%)
Concerns
- Premium to sector peers (P/E 110x vs industry 54.7x)
- High premium to book value (P/B 16.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
GUJTHEM · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 70.87% | 70.87% | 70.87% | 70.87% | 70.87% | 70.87% |
| FII | 0.86% | 1.05% | 1.44% | 1.49% | 1.42% | 1.91% |
| DII | 0.04% | 0.82% | 1.18% | 1.17% | 1.17% | 1.17% |
| Public | 28.23% | 27.26% | 26.52% | 26.47% | 26.55% | 26.05% |
Latest News
All newsGujarat Themis Biosyn submits postal ballot scrutiny report.
*Gujarat Themis Biosyn submits postal ballot scrutiny report.* The company filed the scrutinizer's report related to a recent postal ballot with the NSE. This follows standard corporate procedure for shareholder decisions. No immediate financial impact is indicated. 📊 *STOCKS:* THEMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #PostalBallot
Gujarat Themis Biosyn holds shareholder postal ballot meeting
*Gujarat Themis Biosyn holds shareholder postal ballot meeting.* The company conducted a postal ballot and submitted the scrutinizer’s report with voting results to the exchange. No details on the resolution were disclosed. This is a routine corporate compliance filing. 📊 *STOCKS:* THEMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdersMeeting
Gujarat Themis Biosyn shares to trade ex-dividend today
*Gujarat Themis Biosyn shares to trade ex-dividend today.* The company has declared a final dividend of **₹1.00 per share** for FY23. Shareholders registered before the record date will receive the payout. Trading will be ex-dividend from today onward. 📊 *STOCKS:* GujaratThemis | 🏢 *SECTOR:* Pharma | #LOWIMPACT #dividend
Promoter group indirectly pledges shares of Gujarat Themis Biosyn
*Promoter group indirectly pledges shares of Gujarat Themis Biosyn.* The move involves **GTB** stock pledged through a chain of entities, as per regulatory filings. While no immediate liquidity threat is seen, indirect pledging raises governance concerns. It does not trigger margin calls yet. 📊 *STOCKS:* $GTB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #PromoterPledge
About Gujarat Themis Biosyn Limited
Incorporated in 1981, Gujarat Themis Biosyn Ltd manufactures and sells finished Active Pharmaceutical Ingredients products by fermentation process[1]
HealthcarePharmaceuticals & Biotechnology